BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20427628)

  • 1. Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.
    Geluk A; van der Ploeg-van Schip JJ; van Meijgaarden KE; Commandeur S; Drijfhout JW; Benckhuijsen WE; Franken KL; Naafs B; Ottenhoff TH
    Clin Vaccine Immunol; 2010 Jun; 17(6):993-1004. PubMed ID: 20427628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
    Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
    Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
    Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.
    Geluk A; Bobosha K; van der Ploeg-van Schip JJ; Spencer JS; Banu S; Martins MV; Cho SN; Franken KL; Kim HJ; Bekele Y; Uddin MK; Hadi SA; Aseffa A; Pessolani MC; Pereira GM; Dockrell HM; Ottenhoff TH
    J Immunol; 2012 May; 188(10):4782-91. PubMed ID: 22504648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From genome-based in silico predictions to ex vivo verification of leprosy diagnosis.
    Geluk A; Spencer JS; Bobosha K; Pessolani MC; Pereira GM; Banu S; Honoré N; Reece ST; MacDonald M; Sapkota BR; Ranjit C; Franken KL; Zewdie M; Aseffa A; Hussain R; Stefani MM; Cho SN; Oskam L; Brennan PJ; Dockrell HM;
    Clin Vaccine Immunol; 2009 Mar; 16(3):352-9. PubMed ID: 19176694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
    Lima MC; Pereira GM; Rumjanek FD; Gomes HM; Duppre N; Sampaio EP; Alvim IM; Nery JA; Sarno EN; Pessolani MC
    Scand J Immunol; 2000 Apr; 51(4):419-28. PubMed ID: 10736116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10.
    Spencer JS; Kim HJ; Marques AM; Gonzalez-Juarerro M; Lima MC; Vissa VD; Truman RW; Gennaro ML; Cho SN; Cole ST; Brennan PJ
    Infect Immun; 2004 Jun; 72(6):3161-70. PubMed ID: 15155617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents.
    Dockrell HM; Brahmbhatt S; Robertson BD; Britton S; Fruth U; Gebre N; Hunegnaw M; Hussain R; Manandhar R; Murillo L; Pessolani MC; Roche P; Salgado JL; Sampaio E; Shahid F; Thole JE; Young DB
    Infect Immun; 2000 Oct; 68(10):5846-55. PubMed ID: 10992494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.
    Oliveira RM; Hungria EM; de Araújo Freitas A; de Sousa AL; Costa MB; Reed SG; Duthie MS; Stefani MM
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1415-24. PubMed ID: 24619112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell recognition of peptides from the Mycobacterium leprae 35 kDa protein in Thai leprosy patients, healthy contacts, and non-contacts.
    Chua-Intra B; Wattanapokayakit S; Srisungngam S; Srisungngam T; Mahotarn K; Brennan PJ; Ivanyi J
    Immunol Lett; 2003 Jul; 88(1):71-6. PubMed ID: 12853165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific T-cell responses of leprosy patients.
    Duthie MS; Goto W; Ireton GC; Reece ST; Sampaio LH; Grassi AB; Sousa AL; Martelli CM; Stefani MM; Reed SG
    Clin Vaccine Immunol; 2008 Nov; 15(11):1659-65. PubMed ID: 18784342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
    Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
    Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
    Sampaio LH; Stefani MM; Oliveira RM; Sousa AL; Ireton GC; Reed SG; Duthie MS
    BMC Infect Dis; 2011 Jan; 11():26. PubMed ID: 21269435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium leprae virulence-associated peptides are indicators of exposure to M. leprae in Brazil, Ethiopia and Nepal.
    Bobosha K; Tang ST; van der Ploeg-van Schip JJ; Bekele Y; Martins MV; Lund O; Franken KL; Khadge S; Pontes MA; Gonçalves Hde S; Hussien J; Thapa P; Kunwar CB; Hagge DA; Aseffa A; Pessolani MC; Pereira GM; Ottenhoff TH; Geluk A
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():112-23. PubMed ID: 23283462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of cytokine response against panel of purified Mycobacterium leprae antigens by using whole blood assay in subjects residing in a resettlement village of cured leprosy patients.
    Kamble RR; Shinde VS; Madhale SP; Jadhav RS
    Indian J Lepr; 2010; 82(1):23-31. PubMed ID: 21229844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides Derived from Mycobacterium leprae ML1601c Discriminate between Leprosy Patients and Healthy Endemic Controls.
    Bobosha K; van der Ploeg-van Schip JJ; Esquenazi DA; Guimarães MM; Martins MV; Bekele Y; Fantahun Y; Aseffa A; Franken KL; Gismondi RC; Pessolani MC; Ottenhoff TH; Pereira GM; Geluk A
    J Trop Med; 2012; 2012():132049. PubMed ID: 22363349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine responses to Mycobacterium leprae unique proteins differentiate between Mycobacterium leprae infected and naive armadillos.
    Pena M; Geluk A; Van Der Ploeg-Van Schip JJ; Franken KL; Sharma R; Truman R
    Lepr Rev; 2011 Dec; 82(4):422-31. PubMed ID: 22439281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy.
    Launois P; DeLeys R; Niang MN; Drowart A; Andrien M; Dierckx P; Cartel JL; Sarthou JL; Van Vooren JP; Huygen K
    Infect Immun; 1994 Sep; 62(9):3679-87. PubMed ID: 7520418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy.
    Spencer JS; Dockrell HM; Kim HJ; Marques MA; Williams DL; Martins MV; Martins ML; Lima MC; Sarno EN; Pereira GM; Matos H; Fonseca LS; Sampaio EP; Ottenhoff TH; Geluk A; Cho SN; Stoker NG; Cole ST; Brennan PJ; Pessolani MC
    J Immunol; 2005 Dec; 175(12):7930-8. PubMed ID: 16339528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.